{"disease":{"id":"withdrawal","name":"withdrawal"},"drugs":{"marketed":[{"drug_id":"diazepam","indication_name":"Alcohol withdrawal delirium","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valium","generic_name":"diazepam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2","drug_class":"Benzodiazepine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"diazepam","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valium","generic_name":"diazepam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2","drug_class":"Benzodiazepine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chlordiazepoxide","indication_name":"Alcohol withdrawal delirium","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chlordiazepoxide","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clorazepate","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tranxene","generic_name":"clorazepate","company_name":"Ajenat Pharms","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"methadone","indication_name":"Opioid withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methadone Hydrochloride","generic_name":"METHADONE","company_name":"Specgx Llc","drug_phase":"marketed","molecular_target":"mu-opioid receptors, NMDA receptor","drug_class":"Opioid Agonist","quality_score":66,"revenue":null,"mechanism":"Methadone is a synthetic opioid that acts as a mu-agonist, providing analgesia and aiding in opioid addiction management."},{"drug_id":"diazepam-2mg-encapsulated-tab","indication_name":"Symptomatic relief of acute alcohol withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diazepam 2Mg encapsulated Tab","company_name":"The University of Hong Kong","drug_phase":"marketed","molecular_target":"GABA-A receptor (allosteric modulator)","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clomethiazole","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emineurina","generic_name":"CLOMETHIAZOLE","company_name":"","drug_phase":"discontinued","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"clomethiazole","quality_score":0,"revenue":null,"mechanism":"Emineurina works by enhancing the activity of the neurotransmitter GABA, which helps to calm excessive brain activity."},{"drug_id":"nicotine","indication_name":"Nicotine Withdrawal Symptoms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nicorette","generic_name":"NICOTINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor; alpha4/beta2","drug_class":"Cholinergic Nicotinic Agonist [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"lofexidine","indication_name":"Opioid withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lucemyra","generic_name":"LOFEXIDINE","company_name":"Biocorrx Pharms","drug_phase":"marketed","molecular_target":"Alpha-2A adrenergic receptor","drug_class":"lofexidine","quality_score":null,"revenue":null,"mechanism":"Lucemyra works by activating the alpha-2A adrenergic receptor to reduce the release of norepinephrine, a neurotransmitter involved in withdrawal symptoms."},{"drug_id":"methadon","indication_name":"Opioid withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methadon","company_name":"University of Utah","drug_phase":"discontinued","molecular_target":"Neuronal acetylcholine receptor subunit alpha-10, D(4) dopamine receptor, D(3) dopamine receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":11,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04973202","title":"Portrayal of Hospital Alcohol Detoxification in France","phase":"","overall_status":"COMPLETED","enrollment_count":50000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07466784","title":"CEDRN: Opioid Registry","phase":"","overall_status":"RECRUITING","enrollment_count":7200,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT04422808","title":"AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)","phase":"","overall_status":"COMPLETED","enrollment_count":2437,"lead_sponsor_name":"Wilkes University","has_results":false},{"nct_id":"NCT04057820","title":"Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach","phase":"NA","overall_status":"COMPLETED","enrollment_count":1305,"lead_sponsor_name":"Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program","has_results":true},{"nct_id":"NCT03937180","title":"Blended Care for the Discontinuation of Benzodiazepine Use","phase":"NA","overall_status":"COMPLETED","enrollment_count":924,"lead_sponsor_name":"Kristien Coteur","has_results":false},{"nct_id":"NCT07278375","title":"Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":796,"lead_sponsor_name":"HELP for NOWS Consortium","has_results":false},{"nct_id":"NCT05513872","title":"Overcoming Nicotine Dependence to Enable Quitting","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":780,"lead_sponsor_name":"Rush University Medical Center","has_results":false},{"nct_id":"NCT07368010","title":"End-of-life Care in Mechanically Ventilated Patients: Impact of a Comprehensive Palliative Care Protocol in the Intensive Care Setting","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":720,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT05980260","title":"Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":626,"lead_sponsor_name":"HELP for NOWS Consortium","has_results":false},{"nct_id":"NCT03909191","title":"Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage","phase":"","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT03521115","title":"Family Based Prevention of Alcohol and Risky Sex for Older Teens","phase":"NA","overall_status":"COMPLETED","enrollment_count":411,"lead_sponsor_name":"Pacific Institute for Research and Evaluation","has_results":true},{"nct_id":"NCT06555679","title":"Evaluation of a Predictive Score for the Onset of Moderate to Severe Alcohol Withdrawal Syndrome, the PAWSS, in a Population of Intensive Care Patients at Brest University Hospital","phase":"","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT05336656","title":"Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":353,"lead_sponsor_name":"Wilkes University","has_results":false},{"nct_id":"NCT03557294","title":"Varenicline OTC Trial on Efficacy and Safety","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":313,"lead_sponsor_name":"Arizona State University","has_results":true},{"nct_id":"NCT07338019","title":"The Buzdar Technique","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of Health Sciences Lahore","has_results":false},{"nct_id":"NCT06446349","title":"Brief Motivational Intervention (BMI) on the Deprescription of Benzodiazepines and Related Substances in Adult Chronic Drug Users","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT04610476","title":"Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":270,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT06442566","title":"ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT05461820","title":"Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT05494437","title":"Effect of PP-01 on Cannabis Withdrawal Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"PleoPharma, Inc.","has_results":false},{"nct_id":"NCT04470050","title":"Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT04080037","title":"Assessing Opioid Care Practices Using CPV Patient Simulation Modules","phase":"NA","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Qure Healthcare, LLC","has_results":false},{"nct_id":"NCT04320927","title":"Iatrogenic Withdrawal Symptoms in Severe Traumatic Brain Injury","phase":"","overall_status":"UNKNOWN","enrollment_count":215,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03235531","title":"Assessment of Valproate on Ethanol Withdrawal","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":210,"lead_sponsor_name":"CAMC Health System","has_results":false},{"nct_id":"NCT03737864","title":"NCARE, Transition to Recovery","phase":"NA","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04876443","title":"Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"King's College Hospital NHS Trust","has_results":false},{"nct_id":"NCT06589973","title":"Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients","phase":"","overall_status":"RECRUITING","enrollment_count":195,"lead_sponsor_name":"Hospital General de Mexico","has_results":false},{"nct_id":"NCT04850664","title":"Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":190,"lead_sponsor_name":"Evon Medics LLC","has_results":false},{"nct_id":"NCT04214834","title":"Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":189,"lead_sponsor_name":"Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program","has_results":true},{"nct_id":"NCT05521971","title":"The Impact of a Pharmacist Intervention on Post-discharge Hypnotic Drug Discontinuation in Geriatric Inpatients","phase":"NA","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT05323578","title":"Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05712707","title":"Sublingual Dexmedetomidine for Treating Opioid Withdrawal","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"New York State Psychiatric Institute","has_results":false},{"nct_id":"NCT05382273","title":"Cannabis Tolerance Break Resource Study: T-Break Guide","phase":"","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"University of Vermont","has_results":false},{"nct_id":"NCT06066996","title":"Evaluation of the Electronic Cigarette Withdrawal Syndrome","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05995535","title":"Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT06223191","title":"Reducing Readmissions: BNI Trial in Substance Use Disorder","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Universidad Nacional Autonoma de Honduras","has_results":false},{"nct_id":"NCT04793685","title":"Prazosin for Alcohol Use Disorder With Withdrawal Symptoms","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT00974376","title":"Gabapentin Treatment of Cannabis Dependence","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"The Scripps Research Institute","has_results":true},{"nct_id":"NCT03376308","title":"Evaluation of the Effect of Venous Diameter Measurement by Ultrasonography on Pain and Withdrawal Response","phase":"","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Aydin Adnan Menderes University","has_results":false},{"nct_id":"NCT04156464","title":"Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":142,"lead_sponsor_name":"OSF Healthcare System","has_results":false},{"nct_id":"NCT03918850","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT03485430","title":"Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Lund University Hospital","has_results":false},{"nct_id":"NCT03212547","title":"The Effect of a Neonatologist's Standardized Guidance Intervention on Preterm Infants With Relational Withdrawal.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":140,"lead_sponsor_name":"Clinica Alemana de Santiago","has_results":false},{"nct_id":"NCT06254001","title":"Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":134,"lead_sponsor_name":"National Institute of Respiratory Diseases, Mexico","has_results":false},{"nct_id":"NCT03971097","title":"The Effect of Self-Forgiveness on Self-Stigma in Addiction.","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT03573479","title":"Early Rehabilitation in Critically Ill Children - The PICU Liber8 Study","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT05575219","title":"Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":true},{"nct_id":"NCT03466528","title":"Alcohol: Thiamine and or Magnesium 1","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Glasgow Royal Infirmary","has_results":false},{"nct_id":"NCT04834297","title":"Use of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT07316894","title":"IWS Diagnosis Criteria Consensus","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"ELIAS Emergency University Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}